|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Celgene_Corporation
gptkb:Bristol-Myers_Squibb_Research_Institute
gptkb:Bristol-Myers_Squibb_Global_Corporate_Security
gptkb:Bristol-Myers_Squibb_Global_Manufacturing
gptkb:Immunomedics
gptkb:Bristol-Myers_Squibb_Global_Corporate_Finance
gptkb:Bristol-Myers_Squibb_Global_Corporate_Compliance
gptkb:Bristol-Myers_Squibb_Global_Patient_Safety
gptkb:Bristol-Myers_Squibb_Global_Drug_Development
gptkb:Bristol-Myers_Squibb_Global_Corporate_Operations
gptkb:Bristol-Myers_Squibb_Global_Corporate_Audit
gptkb:Myokardia
gptkb:Bristol-Myers_Squibb_Foundation
gptkb:Bristol-Myers_Squibb_Global_Corporate_Ethics
gptkb:Bristol-Myers_Squibb_Global_Corporate_Information_Technology
gptkb:Bristol-Myers_Squibb_Global_Corporate_Development
gptkb:Celerion
Bristol-Myers_Squibb_Global_Corporate_Communications
Bristol-Myers_Squibb_Clinical_Development
Bristol-Myers_Squibb_Global_Business_Development
Bristol-Myers_Squibb_Global_Clinical_Operations
Bristol-Myers_Squibb_Global_Commercialization
Bristol-Myers_Squibb_Global_Corporate_Affairs
Bristol-Myers_Squibb_Global_Corporate_Governance
Bristol-Myers_Squibb_Global_Corporate_Strategy
Bristol-Myers_Squibb_Global_Corporate_Training
Bristol-Myers_Squibb_Global_Market_Access
Bristol-Myers_Squibb_Global_Medical_Affairs
Bristol-Myers_Squibb_Global_Quality_Assurance
Bristol-Myers_Squibb_Global_Regulatory_Affairs
Bristol-Myers_Squibb_Medical_Affairs
Bristol-Myers_Squibb_Global_Corporate_Responsibility
Bristol-Myers_Squibb_Global_Corporate_Human_Resources
Bristol-Myers_Squibb_Global_Corporate_Risk_Management
|
|
gptkbp:CEO
|
Giovanni Caforio
|
|
gptkbp:drugInterdiction
|
oncology
neuroscience
immunology
virology
cardiovascular
|
|
gptkbp:employees
|
30,000+
|
|
gptkbp:founded
|
1887
|
|
gptkbp:founder
|
gptkb:William_McLaren_Bristol
gptkb:John_Ripley_Myers
|
|
gptkbp:headquarters
|
gptkb:New_York_City
gptkb:United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bristol-Myers Squibb Company, Inc.
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:partnerships
|
gptkb:AstraZeneca
gptkb:NantKwest
gptkb:Pfizer
gptkb:NantWorks
AbbVie
|
|
gptkbp:products
|
gptkb:Opdivo
Eliquis
Yervoy
|
|
gptkbp:revenue
|
$46.4 billion (2020)
|
|
gptkbp:stockSymbol
|
BMY
|
|
gptkbp:subsidiary
|
gptkb:Myocardia,_Inc.
gptkb:Zymeworks_Inc.
|
|
gptkbp:tradedOn
|
gptkb:New_York_Stock_Exchange
|
|
gptkbp:website
|
www.bms.com
|